Table 2. Prevalence of Pain Reported by Cancer Survivors by Cancer Type, Behavioral Risk Factor Surveillance System, 2012–2016.
| Variable | Current Pain (n = 1,146) |
No Current Pain (n = 10,873) |
||||
|---|---|---|---|---|---|---|
| na | Nb | % (95% CI)b | na | Nb | % (95% CI)b | |
| Number of different cancer types | ||||||
| 1 | 842 | 248,970 | 10.6 (9.4–11.9) | 8,543 | 2,095,575 | 89.4 (88.1–90.6) |
| ≥2 | 304 | 75,973 | 12.6 (10.2–15.5) | 2,330 | 528,514 | 87.4 (84.5–89.8) |
| Cancer type | ||||||
| Lung | 62 | 18,117 | 28.3 (19.6–38.9) | 211 | 45,900 | 71.7 (61.1–80.4) |
| Female breast | 398 | 104,506 | 19.1 (16.3–22.4) | 2,236 | 441,556 | 80.9 (77.6–83.7) |
| Leukemia/lymphoma | 69 | 19,286 | 18.0 (12.6–25.1) | 343 | 87,907 | 82.0 (74.9–87.4) |
| Colorectal | 94 | 31,418 | 15.7 (10.0–23.7) | 722 | 168,748 | 84.3 (76.3–90.0) |
| Gynecologic cancers not including cervix | 51 | 10,108 | 7.4 (4.8–11.1) | 575 | 127,318 | 92.6 (88.9–95.2) |
| Cervix | 49 | 17,294 | 6.9 (4.3–10.7) | 731 | 234,629 | 93.1 (89.3–95.7) |
| Prostate | 66 | 20,522 | 5.3 (3.3–8.3) | 1,394 | 368,240 | 94.7 (91.7–96.7) |
| Melanoma | 58 | 16,262 | 2.7 (1.8- 4.1) | 2,220 | 584,729 | 97.3 (95.9–98.2) |
| All other | 278 | 82,986 | 14.0 (11.5–16.9) | 2,131 | 511,203 | 86.0 (83.1–88.5) |
| Age at diagnosis, y | ||||||
| 18–39 | 253 | 108,828 | 15.3 (12.2–19.0) | 1,872 | 604,380 | 84.7 (81.0–87.8) |
| 40–49 | 251 | 67,143 | 14.2 (11.8–17.1) | 1,548 | 405,217 | 85.8 (82.9–88.2) |
| 50–64 | 449 | 105,164 | 10.1 (8.7–11.7) | 3,937 | 938,236 | 89.9 (88.3–91.3) |
| ≥65 | 171 | 37,932 | 5.9 (4.6–7.5) | 3,200 | 607,504 | 94.1 (92.5–95.4) |
| No. years since diagnosis | ||||||
| ≤5 | 402 | 127,788 | 13.0 (10.9–15.4) | 3,293 | 854,978 | 87.0 (84.6–89.1) |
| 6–10 | 263 | 74,862 | 11.9 (9.7–14.6) | 2,177 | 553,115 | 88.1 (85.4–90.3) |
| >10 | 455 | 115,346 | 9.5 (8.0–11.2) | 4,835 | 1,100,442 | 90.5 (88.8–92.0) |
Abbreviation: CI, confidence interval.
a
Unweighted number of respondents.
b
Weighted population number and prevalence.